chr8-127415939-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001159542.3(POU5F1B):​c.73G>C​(p.Ala25Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

POU5F1B
NM_001159542.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0330

Publications

0 publications found
Variant links:
Genes affected
POU5F1B (HGNC:9223): (POU class 5 homeobox 1B) This intronless gene was thought to be a transcribed pseudogene of POU class 5 homeobox 1, however, it has been reported that this gene can encode a functional protein. The encoded protein is nearly the same length as and highly similar to the POU class 5 homeobox 1 transcription factor, has been shown to be a weak transcriptional activator and may play a role in carcinogenesis and eye development. [provided by RefSeq, Apr 2009]
CASC8 (HGNC:45129): (cancer susceptibility 8)
PCAT1 (HGNC:43022): (prostate cancer associated transcript 1) This gene produces a long non-coding RNA that promotes cell proliferation and is upregulated in prostate, colorectal, and other cancers. This RNA negatively regulates the BRCA2 tumor suppressor protein and positively regulates Myc oncoprotein. It contains binding sites for microRNAs, and may act as a sponge for microRNAs that regulate cell growth pathways. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.021825522).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POU5F1BNM_001159542.3 linkc.73G>C p.Ala25Pro missense_variant Exon 1 of 1 ENST00000696633.1 NP_001153014.1 Q06416
POU5F1BNM_001395745.1 linkc.73G>C p.Ala25Pro missense_variant Exon 2 of 2 NP_001382674.1
CASC8NR_117100.1 linkn.1176+4890C>G intron_variant Intron 5 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POU5F1BENST00000696633.1 linkc.73G>C p.Ala25Pro missense_variant Exon 1 of 1 NM_001159542.3 ENSP00000512769.1 Q06416

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000181
AC:
3
AN:
165834
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000243
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000142
AC:
2
AN:
1407936
Hom.:
0
Cov.:
113
AF XY:
0.00000144
AC XY:
1
AN XY:
695498
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32218
American (AMR)
AF:
0.00
AC:
0
AN:
36672
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25088
East Asian (EAS)
AF:
0.0000541
AC:
2
AN:
36998
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79852
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49022
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4908
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1084940
Other (OTH)
AF:
0.00
AC:
0
AN:
58238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 20, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.73G>C (p.A25P) alteration is located in exon 1 (coding exon 1) of the POU5F1B gene. This alteration results from a G to C substitution at nucleotide position 73, causing the alanine (A) at amino acid position 25 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.049
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
0.010
DANN
Benign
0.29
DEOGEN2
Benign
0.00085
T;T
Eigen
Benign
-2.2
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.00015
N
LIST_S2
Benign
0.30
.;T
M_CAP
Benign
0.0010
T
MetaRNN
Benign
0.022
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-2.0
N;N
PhyloP100
0.033
PrimateAI
Benign
0.45
T
PROVEAN
Benign
0.81
.;N
REVEL
Benign
0.089
Sift
Benign
1.0
.;T
Sift4G
Benign
0.32
.;T
Polyphen
0.0
B;B
Vest4
0.075
MutPred
0.11
Gain of disorder (P = 0.1078);Gain of disorder (P = 0.1078);
MVP
0.048
MPC
0.047
ClinPred
0.022
T
GERP RS
0.23
Varity_R
0.048
gMVP
0.14
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs751627167; hg19: chr8-128428184; API